Critical Metals Corp. — Form 6-K Summary
Filing date: October 2, 2026. This is a foreign private issuer’s current report, not a periodic financial-results filing. It concerns transaction agreements, a director’s death, and a financial-advisor settlement.
Business context and transaction changes
Critical Metals previously agreed to acquire all issued shares and listed options of European Lithium Ltd. through two interdependent Australian schemes of arrangement. On September 28, 2026, the companies amended their merger agreement to terminate Critical Metals’ obligation to issue up to 6,778,838 ordinary shares to European Lithium as earnout consideration.
The amendment and a separate agreement terminating the February 2024 Investors Agreement take effect only on the Scheme Implementation Date. Both agreements automatically terminate if the Scheme Implementation Deed is terminated or the Implementation Date does not occur. The filing does not report that the transaction has closed.
Financial and liquidity information
The filing provides no new revenue, profit, cash-flow, margin, debt, or liquidity figures. Under an October 1 settlement ending prior engagement arrangements with a financial advisor, Critical Metals must pay $5 million in cash and issue approximately 1.1 million ordinary shares. The company must file a resale registration statement for those shares within 30 days and use reasonable best efforts to make it effective as soon as practicable, no later than 120 days after the agreement.
Other developments, outlook, and risks
- Director Michael C. Ryan, who had served on the board since February 2025, died on September 27, 2026.
- The company cautions that forward-looking statements, including those about transaction timing and benefits, are subject to risks and uncertainties and are not guarantees of performance. It refers investors to the risk factors in its latest Form 20-F, as amended.
- The filing does not provide updated financial guidance or quantify the settlement’s effect on cash, liquidity, or dilution.
Key facts for investors to verify
- Whether the European Lithium schemes reach the Implementation Date, and the resulting status of the merger amendment and Investors Agreement termination.
- The final number of advisor shares issued, completion of the $5 million cash payment, and filing and effectiveness of the resale registration statement.
- Any subsequent company disclosures on transaction progress, liquidity impact, or board composition following Mr. Ryan’s death.